Royal Bank Of Canada Gh Research PLC Transaction History
Royal Bank Of Canada
- $422 Billion
- Q1 2024
A detailed history of Royal Bank Of Canada transactions in Gh Research PLC stock. As of the latest transaction made, Royal Bank Of Canada holds 1,000 shares of GHRS stock, worth $11,750. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,000
Previous 1,000
-0.0%
Holding current value
$11,750
Previous $5,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding GHRS
# of Institutions
36Shares Held
17MCall Options Held
25.5KPut Options Held
19.8K-
Bvf Inc San Francisco, CA10.4MShares$122 Million3.32% of portfolio
-
Rtw Investments, LP New York, NY3.33MShares$39.1 Million0.57% of portfolio
-
Verition Fund Management LLC Greenwich, CT1.13MShares$13.3 Million0.09% of portfolio
-
Cormorant Asset Management, LP Boston, MA593KShares$6.97 Million0.36% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA573KShares$6.73 Million2.15% of portfolio
About GH Research PLC
- Ticker GHRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,020,800
- Market Cap $611M
- Description
- GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies for the treatment of psychiatric and neurological disorders. The company focuses on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). Its lead program is GH0...